4//SEC Filing
Accardi Mario Alberto 4
Accession 0001470831-25-000390
CIK 0001847903other
Filed
Dec 8, 7:00 PM ET
Accepted
Dec 9, 7:07 PM ET
Size
7.7 KB
Accession
0001470831-25-000390
Insider Transaction Report
Form 4
Accardi Mario Alberto
President, Orexin Program
Transactions
- Sale
Ordinary Shares
2025-12-09$28.70/sh−7,432$213,284→ 181,369 total - Sale
Ordinary Shares
2025-12-09$29.21/sh−2,568$75,005→ 178,801 total
Footnotes (4)
- [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 14, 2025.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.43 to $28.9575, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.015 to $29.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Documents
Issuer
Centessa Pharmaceuticals plc
CIK 0001847903
Entity typeother
Related Parties
1- filerCIK 0002074392
Filing Metadata
- Form type
- 4
- Filed
- Dec 8, 7:00 PM ET
- Accepted
- Dec 9, 7:07 PM ET
- Size
- 7.7 KB